[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350328-105":59,"doc-detail-350328-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","possible-founder-effect-of-the-cdkn2a-c146tc-variant-in-the-mexican-population-phenotypic-characterization","Possible Founder Effect of the CDKN2A c.146T>C Variant in the Mexican Population - Phenotypic Characterization","","Background: Germline CDKN2A variants are linked to Familial Atypical MoleMelignant Melanoma (FAMMM) syndrome, increasing risks of melanoma, pancreatic cancer, and other cancers in specific populations. The CDKN2A (c.146T>C) variant has been reported in Mexican hereditary cancer patients, with a phenotype that may differ across groups. This study evaluates founder effect using epidemiological analysis and characterizes the associated phenotype in the study population. Patients and Methods: 72 Mexican patients carrying CDKN2A (c.146T>C) were examined. Results: 52 (72.22%) tested positive, and 27 (37.50%) had a cancer diagnosis. Breast cancer was most common (70.37%), followed by melanoma (14.81%) and ovarian cancer (7.40%). Conclusions: Findings support a founder effect in Mexico and suggest phenotype variation, with breast cancer predominating over melanoma and emphasizing updated screening guidance.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/possible-founder-effect-of-the-cdkn2a-c146tc-variant-in-the-mexican-population-phenotypic-characterization/350328/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/possible-founder-effect-of-the-cdkn2a-c146tc-variant-in-the-mexican-population-phenotypic-characterization/350328.png","ImageObject",300,407,{"name":92,"@type":93},"Cipher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What condition is associated with germline CDKN2A variants and what cancers are involved?","Question",{"text":112,"@type":113},"Germline CDKN2A variants are associated with FAMMM syndrome, which increases the risk of melanoma and pancreatic cancer, and in specific populations also relates to other cancers including breast cancer and astrocytoma.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the founder effect of the CDKN2A c.146T>C variant evaluated in this study?",{"text":117,"@type":113},"Founder effect was assessed through epidemiological analysis of 72 Mexican patients carrying the CDKN2A (c.146T>C) variant across hereditary cancer centers between September 2023 and September 2025.",{"name":119,"@type":110,"acceptedAnswer":120},"What phenotype did the CDKN2A c.146T>C variant show in the Mexican population?",{"text":121,"@type":113},"Among individuals analyzed, breast cancer was the most common neoplasia (70.37%), followed by melanoma (14.81%) and ovarian cancer (7.40%), supporting phenotype variation in Mexican carriers.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350328,1790839061,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687208528416,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Article  \nPossible Founder Effect of the CDKN2A c.146T>C Variant in the Mexican Population: Phenotypic Characterization  \nMaría Lourdes Garza-Rodríguez 1, Eren Adrián Alejandro Vargas-Márquez 1,2, Dione Aguilar 3, Samantha Trujillo-Bornios 1, Hugo Leonid Gallardo-Blanco 1, Oscar Vidal-Gutiérrez 1,  \nDiana Cristina Pérez-Ibave 1,* and Carlos Horacio Burciaga-Flores 1,4, *  \nAcademic Editor: Hui Li  \nReceived: 26 March 2026  \nRevised: 23 April 2026  \nAccepted: 28 April 2026  \nPublished: 30 April 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Servicio de Oncología, Centro Universitario Contra el Cáncer (CUCC), Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey 66451, Nuevo Leon, Mexico; [maria.garzarg@unal.edu.mx](maria.garzarg@unal.edu.mx) (M.L.G.-R.); [evargasm2400@alumno.ipn.mx](evargasm2400@alumno.ipn.mx) (E.A.A.V.-M.);  \n[stbbts13@gmail.com](stbbts13@gmail.com) (S.T.-B.); [hugo.gallardobl@uanl.edu.mx](hugo.gallardobl@uanl.edu.mx) (H.L.G.-B.);  \n[oscar.vidalgtz@uanl.edu.mx](oscar.vidalgtz@uanl.edu.mx) (O.V.-G.)  \n2 Laboratorio de Medicina de Conservación, Centro de Biotecnología Genómica, Instituto Politécnico Nacional (IPN), Reynosa 88710, Tamaulipas, Mexico  \n3 Breast Cancer Center, Hospital Zambrano Hellion TecSalud,  \nSan Pedro Garza Garcia 66260, Nuevo Leon, Mexico; [dra.dioneaguilar@tecsalud.mx](dra.dioneaguilar@tecsalud.mx)  \n[4](4 Instituto Mexicano del Seguro Social)[ Instituto Mexicano del Seguro Social](4 Instituto Mexicano del Seguro Social) ([IMSS](IMSS)), Hospital de Ginecología y Obstetricia No. 23, Monterrey 64000, Nuevo Leon, Mexico  \n* Correspondence: [dperezi@uanl.edu.mx](dperezi@uanl.edu.mx) (D.C.P.-I.); [carlos.hburciaga@gmail.com](carlos.hburciaga@gmail.com) (C.H.B.-F.)  \nAbstract  \nBackground: Germline CDKN2A variants are associated with Familial Atypical MoleMalignant Melanoma (FAMMM) syndrome. This syndrome involves an increased risk of melanoma, pancreatic cancer, and, in specific populations, duodenal cancer, breast cancer, and astrocytoma. The CDKN2A (c.146T>C) variant has been found in hereditary cancer patients within the Mexican population. Furthermore, the phenotype linked to this variant in Mexico differs from that observed in other groups. This study aims to evaluate the founder effect of the CDKN2A (c.146T>C) variant through epidemiological analysis and to describe the phenotype within our population. Patients and Methods: We examined 72 Mexican patients (14 probands from distinct families, 48 relatives, and 10 nonrelated probands) carrying the CDKN2A (c.146T>C) form three hereditary cancer centers between September 2023 and September 2025 . Results: Of the 72 individuals analyzed, 52 (72.22%) tested positive. A cancer diagnosis was established in 27 (37.50%) of the individuals analyzed. Breast cancer was the most common neoplasia, accounting for 19 cases (70.37%), followed by melanoma with 4 cases (14.81%) and ovarian cancer with 2 cases (7.40%) . Three patients (11.11%) had two distinct primary neoplasms. Conclusions: Based on our findings and the fact that this variant has been reported nearly exclusively in the Mexican population, we conclude that it has a founder effect in this population. Additionally, the phenotype associated with this variant can vary among populations, with breast cancer being the most common carcinoma rather than melanoma among Mexican carriers, highlighting the importance of updating screening guidelines.  \nKeywords: CDKN2A; germline variant; founder effect; breast cancer; hereditary cancer  \n1. Introduction  \nFamilial Atypical Multiple-Mole Melanoma (FAMMM) is an autosomal dominant hereditary cancer syndrome marked by familial melanoma and atypical nevi [1], caused by  \ngermline variants in CDKN2A. Besides melanoma, CDKN2A carriers also have higher r","cbCaiimPaTuB5WhS","https://ap.wps.com/l/cbCaiimPaTuB5WhS","pdf",391793,11,"English","# Abstract\n## Background\n## Patients and Methods\n## Results\n## Conclusions\n# 1. Introduction\n## Familial Atypical Multiple-Mole Melanoma (FAMMM)\n## CDKN2A gene structure and function\n## Cancer risks linked to CDKN2A variants","[{\"question\":\"What condition is associated with germline CDKN2A variants and what cancers are involved?\",\"answer\":\"Germline CDKN2A variants are associated with FAMMM syndrome, which increases the risk of melanoma and pancreatic cancer, and in specific populations also relates to other cancers including breast cancer and astrocytoma.\"},{\"question\":\"How was the founder effect of the CDKN2A c.146T\\u003eC variant evaluated in this study?\",\"answer\":\"Founder effect was assessed through epidemiological analysis of 72 Mexican patients carrying the CDKN2A (c.146T\\u003eC) variant across hereditary cancer centers between September 2023 and September 2025.\"},{\"question\":\"What phenotype did the CDKN2A c.146T\\u003eC variant show in the Mexican population?\",\"answer\":\"Among individuals analyzed, breast cancer was the most common neoplasia (70.37%), followed by melanoma (14.81%) and ovarian cancer (7.40%), supporting phenotype variation in Mexican carriers.\"}]","Possible Founder Effect of the CDKN2A c.146T>C Variant in the Mexican Population - Phenotypic Characterization | PDF",1790088480,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e160e6725ace68fd7fef774910bfaa11.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cb1401e702842b17b561046505b4293d.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/55330cbd491952750a2adcc6395c1a8f.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/20c131f77433d04304336ccd5368059a.webp",980,1385]